Mitochondrial defects in cardiomyopathy and neuromuscular disease

American Heart Journal

Volumn 139, Issue 2 III, 2000, Pages

  Wallace, D C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CARDIOMYOPATHY; CONFERENCE PAPER; DEGENERATIVE DISEASE; ENERGY METABOLISM; GENE MUTATION; HEART DILATATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MITOCHONDRION; NEUROMUSCULAR DISEASE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0033981680     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.103934     Document Type: Conference Paper

References (151)

1. Wallace DC, Lott MT. Maternally inherited diseases. In: DiMauro S, Wallace DC, editors. Mitochondrial DNA in human pathology. New York: Raven Press; 1992. p. 63-83.
2. Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 1992;256:628-32.
3. Wallace DC. Mitochondrial DNA variation in human evolution, degenerative disease, and aging. Am J Hum Genet 1995;57: 201-23.
4. Wallace DC, Lott MT, Brown MD, Kerstann K. Mitochondria and neuro-ophthalmological diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill. In press.
5. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999;283:1482-8.
6. Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem 1992;61:1175-212.
7. Wallace DC. Mitochondrial DNA mutations and bioenergetic defects in aging and degenerative diseases. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, editors. The molecular and genetic basis of neurological disease. Boston: Butterworth-Heinemann; 1997. p. 237-69.
8. Wallace DC, Brown MD, Lott MT. Mitochondrial genetics. In: Rimoin DL, Connor JM, Pyeritz RE, Emery AEH, editors. Emery and Rimoin's principles and practice of medical genetics. London: Churchill Livingstone; 1996. p. 277-332.
9. Petit PX, Susin SA, Zamzami N, Mignotte B, Kroemer G. Mitochondria and programmed cell death: back to the future. FEBS Lett 1996;396:7-13.
10. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281:1309-12.
11. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta 1995;1241:139-76.
12. Mancini M, Nicholson DW, Roy S, et al. The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol 1998;140:1485-95.
13. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996;86:147-57.
14. Earnshaw WC. Apoptosis: a cellular poison cupboard. Nature 1999;397:387, 389.
15. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441-6.
16. Susin SA, Lorenzo HK, Zamzami N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 1999;189:381-94.
17. Brustovetsky N, Klingenberg M. Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. Biochem 1996;35:8483-8.
18. Marzo I, Brenner C, Zamzami N, et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998;281:2027-31.
19. Bunn CL, Wallace DC, Eisenstadt JM. Cytoplasmic inheritance of chloramphenicol resistance in mouse tissue culture cells. Proc Natl Acad Sci USA 1974;71:1681-5.
20. Wallace DC, Bunn CL, Eisenstadt JM. Cytoplasmic transfer of chlor-amphenicol resistance in human tissue culture cells. J Cell Biol 1975;67:174-88.
21. Blanc H, Adams CW, Wallace DC. Different nucleotide changes in the large rRNA gene of the mitochondrial DNA confer chloramphenicol resistance on two human cell lines. Nucleic Acids Res 1981;9:5785-95.
22. Blanc H, Wright CT, Bibb MJ, Wallace DC, Clayton DA. Mitochondrial DNA of chloramphenicol-resistant mouse cells contains a single nucleotide change in the region encoding the 3′ end of the large ribosomal RNA. Proc Natl Acad Sci USA 1981;78:3789-93.
23. Levy SE, Waymire KG, MacGregor GR, Kim YL, Wallace DC. Transfer of chloramphenicol-resistant mitochondrial DNA into the chimeric mouse. Transgenic Res 1999;2179:1-9.
24. King MP, Attardi G. Injection of mitochondria into human cells leads to a rapid replacement of the endogenous mitochondrial DNA. Cell 1988;52:811-9.
25. Ziegler ML, Davidson RL. Elimination of mitochondrial elements and improved viability in hybrid cells. Somatic Cell Genet 1981;7:73-88.
26. Trounce I, Wallace DC. Production of transmitochondrial mouse cell lines by cybrid rescue of rhodamine-6G pre-treated L-cells. Somat Cell Mol Genet 1996;22:81-5.
27. Case JT, Wallace DC. Maternal inheritance of mitochondrial DNA polymorphisms in cultured human fibroblasts. Somatic Cell Genet 1981;7:103-8.
28. Giles RE, Blanc H, Cann HM, Wallace DC. Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci USA 1980;77:6715-9.
29. Michaels GS, Hauswirth WW, Laipis PJ. Mitochondrial DNA copy number in bovine oocytes and somatic cells. Dev Biol 1982;94:246-51.
30. Chen X, Prosser R, Simonetti S, Sadlock J, Jagiello G, Schon EA. Rearranged mitochondrial genomes are present in human oocytes. Am J Hum Genet 1995;57:239-47.
31. Wallace DC, Ye JH, Neckelmann SN, Singh G, Webster KA, Greenberg BD. Sequence analysis of cDNAs for the human and bovine ATP synthase β-subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet 1987;12:81-90.
32. Neckelmann N, Li K, Wade RP, Shuster R, Wallace DC. cDNA sequence of a human skeletal muscle ADP/ATP translocator: lack of a leader peptide, divergence from a fibroblast translocator cDNA, and coevolution with mitochondrial DNA genes. Proc Natl Acad Sci USA 1987;84:7580-4.
33. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 1990;61:931-7.
34. Wallace DC, Lott MT, Shoffner JM, Ballinger S. Mitochondrial DNA mutations in epilepsy and neurological disease. Epilepsia 1994;35(suppl 1):S43-S50.
35. Wallace DC, Zheng X, Lott MT, et al. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 1988;5:601-10.
36. Wallace DC. Mitochondrial diseases: genotype versus phenotype. Trends Genet 1993;9128-33.
37. Attardi G, Yoneda M, Chomyn A. Complementation and segregation behavior of disease-causing mitochondrial DNA mutations in cellular model systems. Biochim Biophys Acta 1995;1271:241-8.
38. Wallace DC, Brown MD, Lott MT. Mitochondrial DNA variation in human evolution and disease. Gene. 1999;238:211-30.
39. Chen YS, Torroni A, Excoffier L, Santachiara-Benerecetti AS, Wallace DC. Analysis of mtDNA variation in African populations reveals the most ancient of all human continent-specific haplogroups. Am J Hum Genet 1995;57:133-49.
40. Chen YS, Olckers A, Schurr TG, Kogelnik AM, Huoponen K, Wallace DC. Mitochondrial DNA variation in the South African Kung and Khwe and their genetic relationship to other African populations. Am J Hum Genet 2000 (January); in press.
41. Torroni A, Lott MT, Cabell MF, Chen Y, Laverge L, Wallace DC. MtDNA and the origin of caucasians. Identification of ancient caucasian-specific haplogroups, one of which is prone to a recurrent somatic duplication in the D-loop region. Am J Hum Genet 1994;55:760-76.
42. Torroni A, Huoponen K, Francalacci P, et al. Classification of European mtDNAs from an analysis of three European populations. Genetics 1996;144:1835-50.
43. Ballinger SW, Schurr TG, Torroni A, et al. Southeast Asian mitochondrial DNA analysis reveals genetic continuity of ancient mongoloid migrations [published erratum appears in Genetics 1992;130:957]. Genetics 1992;130:139-52.
44. Torroni A, Miller JA, Moore LG, et al. Mitochondrial DNA analysis in Tibet: implications for the origin of the Tibetan population and its adaptation to high altitude. Am J Phys Anthropol 1994;93:189-99.
45. Wallace DC, Torroni A. American Indian prehistory as written in the mitochondrial DNA: a review. Hum Biol 1992;64:403-16.
46. Torroni A, Schurr TG, Yang C-C, et al. Native American mitochondrial DNA analysis indicates that the Amerind and the Nadene populations were founded by two independent migrations. Genetics 1992;130:153-62.
47. Torroni A, Schurr TG, Cabell MF, et al. Asian affinities and continental radiation of the four founding Native American mtDNAs. Am J Hum Genet 1993;53:563-90.
48. Torroni A, Chen Y, Semino O, et al. MtDNA and Y-chromosome polymorphisms in four native American populations from southern Mexico. Am J Hum Genet 1994;54:303-18.
49. Torroni A, Neel JV, Barrantes R, Schurr TG, Wallace DC. A mitochondrial DNA "clock" for the Amerinds and its implication for timing their entry into North America. Proc Natl Acad Sci USA 1994;91:1158-62.
50. Schurr TG, Sukernik RI, Starikovskaya YB, Wallace DC. Mitochondrial DNA variation in Koryaks and Itel'men: population replacement in the Okhotsk Sea-Bering Sea region during the Neolithic. Am J Phys Anthropol 1999;108:1-39.
51. Starikovskaya YB, Sukernik RI, Schurr TG, Kogelnik AM, Wallace DC. Mitochondrial DNA diversity in Chukchi and Siberian Eskimos: implications for genetic history of ancient Beringia and peopling of the New World. Am J Hum Genet 1998;63:1473-91.
52. Huoponen K, Torroni A, Wickman PR, et al. Mitochondrial DNA and Y chromosome-specific polymorphisms in the Seminole tribe of Florida. Eur J Hum Genet 1997;5:25-34.
53. Brown MD, Hosseini SH, Torroni A, et al. mtDNA haplogroup X: an ancient link between Europe/Western Asia and North America? Am J Hum Genet 1998;63:1852-61.
54. Shoffner JM, Brown MD, Stugard C, et al. Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation in a complex I subunit. Ann Neurol 1995;38:163-9.
55. Ortiz RG, Newman NJ, Manoukian SV, Diesenhouse MC, Lott MT, Wallace DC. Optic disk cupping and electrocardiographic abnormalities in an American pedigree with Leber's hereditary optic neuropathy. Am J Ophthalmol 1992;113:561-6.
56. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988;242:1427-30.
57. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the ND6 gene associated with maternally inherited Leber's hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 1994;91:6206-10.
58. Jun AS, Trounce IA, Brown MD, Shoffner JM, Wallace DC. Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase sub-unit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia. Mol Cell Biol 1996;16:771-7.
59. Huoponen K, Vilkki J, Aula P, Nikoskelainen EK, Savontaus ML. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet 1991;48:1147-53.
60. Howell N, Bindoff LA, McCullough DA, et al. Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet 1991;49:939-50.
61. Johns DR, Neufeld MJ, Park RD. An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun 1992;187:1551-7.
62. Mackey D, Howell N. A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by an unusual mitochondrial genetic etiology. Am J Hum Genet 1992;51:1218-28.
63. Biousse V, Brown MD, Newman NJ, et al. De novo 14484 mitochondrial DNA mutation in monozygotic twins discordant for Leber's hereditary optic neuropathy. Neurology 1997;49:1136-8.
64. Brown MD, Torroni A, Reckord CL, Wallace DC. Phylogenetic analysis of Leber's hereditary optic neuropathy mitochondrial DNA's indicates multiple independent occurrences of the common mutations. Hum Mutat 1995;6:311-25.
65. Brown MD, Sun F, Wallace DC. Clustering of caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet 1997;60:381-7.
66. Torroni A, Carelli V, Petrozzi M, et al. Detection of the mtDNA 14484 mutation on an African-specific haplotype: implications about its role in causing Leber hereditary optic neuropathy. Am J Hum Genet 1996;59:248-52.
67. Brown MD, Voljavec AS, Lott MT, MacDonald I, Wallace DC. Leber's hereditary optic neuropathy: a model for mitochondrial neurodegenerative diseases. FASEB J 1992;6:2791-9.
68. Brown MD, Shoffner JM, Kim YL, et al. Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. Am J Hum Genet 1996;61:283-9.
69. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428-33.
70. De Vries DD, Van Engelen BG, Gabreels FJ, Ruitenbeek W, Van Oost BA. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann Neurol 1993;34:410-2.
71. Santorelli FM, Shanske S, Jain KD, Tick D, Schon EA, DiMauro S. A T-C mutation at nt 8993 of mitochondrial DNA in a child with Leigh syndrome. Neurology 1994;44:972-4.
72. Thyagarajan D, Shanske S, Vazquez-Memije M, De Vivo D, DiMauro S. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol 1995;38:468-72.
73. Kretzchmar HA, DeArmond SJ, Koch TK, et al. Pyruvate dehydrogenase complex deficiency as a cause of subacute necrotizing encephalopathy (Leigh's disease). Pediatrics 1987;79:370-3.
74. Robinson BH, De Meirleir L, Glerum M, Sherwood G, Becker L. Clinical presentation of mitochondrial respiratory chain defects in NADH-coenzyme Q reductase and cytochrome oxidase: clues to pathogenesis of Leigh disease. J Pediatr 1987;110:216-22.
75. Matthews PM, Marchington DR, Squier M, et al. Molecular genetic characterization of an X-linked form of Leigh's syndrome. Ann Neurol 1993;33:652-5.
76. Tiranti V, Hoertnagel K, Carrozzo R, et al. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 1998;63:1609-21.
77. Zhu Z, Yao J, Johns T, et al. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nature Genet 1998;20:337-43.
78. Miranda AF, Ishii S, DiMauro S, Shay JW. Cytochrome c oxidase deficiency in Leigh's syndrome: genetic evidence for a nuclear DNA-encoded mutation. Neurology 1989;39:697-702.
79. DiMauro S, Servidei S, Zeviani M, et al. Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol 1987;22:498-506.
80. Smeitink J, van den Heuvel L. Protein biosynthesis '99. Human mitochondrial complex I in health and disease. Am J Hum Genet 1999;4:1505-10.
81. Bourgeron T, Rustin P, Chretien D, et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genet 1995;11:144-9.
82. Hommes FA, Polman HA, Reerink JD. Leigh's encephalomyelopathy: an inborn error of gluconeogenesis. Arch Dis Child 1968;43:423-6.
83. Ortiz RG, Newman NJ, Shoffner JM, Kaufman AE, Koontz DA, Wallace DC. Variable retinal and neurologic manifestations in patients harboring the mitochondrial DNA 8993 mutation. Arch Ophthalmol 1993;111:1525-30.
84. Santorelli FM, Shanske S, Macaya A, DeVivo DC, DiMauro S. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol 1993;34:827-34.
85. Shoffner JM, Fernhoff MD, Krawiecki NS, et al. Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology 1992;42:2168-74.
86. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992;50:852-8.
87. Trounce I, Neill S, Wallace DC. Cytoplasmic transfer of the mtDNA nt 8993 TG (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio. Proc Natl Acad Sci USA 1994;91:8334-8.
88. Wallace DC, Lott MT, Kogelnik AM, Katdare G, Brown MD, Navathe SB. MITOMAP: A Human mitochondrial genome database. Atlanta (GA): Emory University, Center for Molecular Medicine; 1999.
89. Wallace DC. Mitochondrial DNA mutations in diseases of energy metabolism. J Bioenerg Biomembr 1994;26:241-50.
90. Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-3.
91. Kobayashi Y, Momoi MY, Tominaga K, et al. A point mutation in the mitochondrial tRNALeu(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun 1990;173:816-22.
92. van den Ouweland JM, Lemkes HHP, Ruitenbeek W, et al. Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genet 1992;1:368-71.
93. van den Ouweland JM, Lemkes HH, Trembath RC, et al. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNALeu(UUR) gene. Diabetes 1994;43:746-51.
94. Gerbitz KD, van den Ouweland JM, Maassen JA, Jaksch M. Mitochondrial diabetes mellitus: a review. Biochim Biophys Acta 1995;1271:253-60.
95. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994;330:962-8.
96. Wallace DC, Lott MT, Brown MD. Mitochondrial defects in neurodegenerative diseases and aging. In: Beal MF, editor. Mitochondria and free radicals in neurodegenerative diseases. New York: Wiley; 1997.
97. Shoffner JM, Bialer MG, Pavlakis SG, et al. Mitochondrial encephalomyopathy associated with a single nucleotide pair deletion in the mitochondrial tRNALeu(UUR) gene. Neurology 1995;45:286-92.
98. Moraes CT, Ricci E, Bonilla E, DiMauro S, Schon EA. The mitochondrial tRNALeu(UUR) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am J Hum Genet 1992;50:934-49.
99. De Vries D, De Wijs I, Ruitenbeek W, et al. Extreme variability of clinical symptoms among sibs in a MELAS family correlated with heteroplasmy for the mitochondrial A3243G mutation. J Neurol Sci 1994;124:77-82.
100. Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992;42:545-50.
101. Mariotti C, Savarese N, Suomalainen A, et al. Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol 1995;242:304-12.
102. Obermaier-Kusser B, Paetzke-Brunner I, Enter C, et al. Respiratory chain activity in tissues from patients (MELAS) with a point mutation of the mitochondrial genome (tRNALeu(UUR)). FEBS Lett 1991; 286:67-70.
103. Chomyn A, Martinuzzi A, Yoneda M, et al. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci USA 1992;89:4221-5.
104. King MP, Koga Y, Davidson M, Schon EA. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNALeu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Mol Cell Biol 1992;12:480-90.
105. Koga Y, Davidson M, Schon EA, King MP. Analysis of cybrids harboring MELAS mutations in the mitochondrial tRNALeu(UUR) gene. Muscle Nerve 1995;3:S119-23.
106. Seibel P, Degoul F, Bonne G, et al. Genetic biochemical and pathophysiological characterization of a familial mitochondrial encephalomyopathy (MERRF). J Neurol Sci 1991;105:217-24.
107. Boulet L, Karpati G, Shoubridge EA. Distribution and threshold expression of the tRNALys mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 1992;51:1187-200.
108. Chomyn A, Meola G, Bresolin N, Lai ST, Scarlato G, Attardi G. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol Cell Biol 1991;11:2236-44.
109. Masucci JP, Davidson M, Koga Y, Schon EA, King MP. In vitro analysis of mutations causing myoclonus epilepsy with ragged-red fibers in the mitochondrial tRNALys gene: two genotypes produce similar phenotypes. Mol Cell Biol 1995;15:2872-81.
110. Noer AS, Sudoya H, Lertrit P, et al. A tRNA(Lys) mutation in the mtDNA is the causal genetic lesion underlying myoclonic epilepsy and ragged-red fiber (MERRF) syndrome. Am J Hum Genet 1991;49:715-22.
111. Enriquez JA, Chomyn A, Attardi G. MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNALys and premature translation termination. Nature Genet 1995;10:47-55.
112. Shoffner JM, Brown MD, Torroni A, et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993;17:171-84.
113. Hutchin T, Cortopassi G. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci USA 1995;92:6892-5.
114. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717-9.
115. Moraes CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989;20:1293-9.
116. Poulton J, Deadman ME, Gardiner RM. Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet 1989;1:236-40.
117. Poulton J, Deadman ME, Bindoff L, Morten K, Land J, Brown G. Families of mtDNA re-arrangements can be detected in patients with mtDNA deletions: duplications may be a transient intermediate form. Hum Mol Genet 1993;2:23-30.
118. Poulton J, Holt I. Mitochondrial DNA: does more lead to less? Nature Genet 1994;8:313-5.
119. Rotig A, Colonna M, Bonnefont JP, et al. Mitochondrial DNA deletion in Pearson's marrow-pancreas syndrome. Lancet 1989;1:902-3.
120. Rotig A, Cormier V, Blanche S, et al. Pearson's marrow-pancreas syndrome. A multi-system mitochondrial disorder in infancy. J Clin Invest 1990;86:1601-8.
121. Ballinger SW, Shoffner JM, Hedaya EV, et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genet 1992;1:11-5.
122. Ballinger SW, Shoffner JM, Gebhart S, et al. Mitochondrial diabetes revisited [letter]. Nature Genet 1994;7:458-9.
123. Mita S, Schmidt B, Schon EA, DiMauro S, Bonilla E. Detection of "deleted" mitochondrial genomes in cytochrome-c oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome. Proc Natl Acad Sci USA 1989;86:9509-13.
124. Larsson NG, Holme E, Kristiansson B, Oldfors A, Tulinius, M. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res 1990;28:131-6.
125. Shoubridge EA, Karpati G, Hastings KEM. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell 1990;62:43-9.
126. Kawai H, Akaike M, Yokoi K, et al. Mitochondrial encephalomyopathy with autosomal dominant inheritance: a clinical and genetic entity of mitochondrial diseases. Muscle Nerve 1995;18:753-60.
127. Suomalainen A, Kaukonen J, Amati P, et al. An autosomal locus predisposing to deletions of mitochondrial DNA. Nature Genet 1995;9:146-51.
128. Kaukonen J, Amati P, Suomalainen A, et al. Identification of a second autosomal locus predisposing to multiple deletions of mitochondrial DNA [abstract]. Am J Hum Genet 1995;57:A216.
129. Kaukonen JA, Amati P, Suomalainen A, et al. An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p. Am J Hum Genet 1996;58:763-9.
130. Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res 1992;275:169-80.
131. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet 1992;2:324-9.
132. Melov S, Coskun EP, Wallace DC. Mouse models of mitochondrial disease, oxidative stress, and senescence. Mutat Res. In press.
133. Melov S, Shoffner JM, Kaufman A, Wallace DC. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle [published erratum appears in Nucleic Acids Res 1995;23:4938]. Nucleic Acids Res 1995; 23:4122-6.
134. Melov S, Hinerfeld D, Esposito L, Wallace DC. Multi-organ characterization of mitochondrial genomic rearrangements in ad libitum and caloric restricted mice show striking somatic mitochondrial DNA rearrangements with age. Nucleic Acids Res 1997;25:974-82.
135. Mecocci P, MacGarvey U, Kaufman AE, et al. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993;34:609-16.
136. Corral-Debrinski M, Horton T, Lott MT, et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 1994;23:471-6.
137. Horton TM, Graham BH, Corral-Debrinski M, et al. Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington's disease patients. Neurology 1995;45:1879-83.
138. Heddi A, Lestienne P, Wallace DC, Stepien G. Mitochondrial DNA expression in mitochondrial myopathies and coordinated expression of nuclear genes involved in ATP production. J Biol Chem 1993;268:12156-63.
139. Heddi A, Lestienne P, Wallace DC, Stepien G. Steady state levels of mitochondrial and nuclear oxidative phosphorylation transcripts in Kearns-Sayre syndrome. Biochim Biophys Acta 1994;1226: 206-12.
140. Heddi A, Stepien G, Benke PJ, Wallace DC. Coordinate induction of energy gene expression in tissues of mitochondrial disease patients. J Biol Chem 1999;274:22968-76.
141. Haraguchi Y, Chung AB, Torroni A, et al. Genetic mapping of human heart-skeletal muscle adenine nucleotide translocator and its relationship to the fascioscapulohumeral muscular dystrophy locus. Genomics 1993;16:479-85.
142. Haraguchi Y, Chung AB, Neill S, Wallace DC. OXBOX and REBOX, overlapping promoter elements of the mitochondrial F0F1-ATP synthase beta subunit gene. OXBOX/REBOX in the ATPsyn beta promoter. J Biol Chem 1994;269:9330-4.
143. Chung AB, Stepien G, Haraguchi Y, Li K, Wallace DC. Transcriptional control of nuclear genes for the mitochondrial muscle ADP/ATP translocator and the ATP synthase beta subunit. Multiple factors interact with the OXBOX/REBOX promoter sequences. J Biol Chem 1992;267:21154-61.
144. Graham B, Waymire K, Cottrell B, Trounce IA, MacGregor GR, Wallace DC. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/skeletal muscle isoform of the adenine nucleotide translocator. Nature Genet 1997;16:226-34.
145. Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC. Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 1999;96:4820-5.
146. Murdock D, Boone BE, Esposito L, Wallace DC. Up-regulation of nuclear and mitochondrial genes in the skeletal muscle of mice lacking the heart/muscle isoform of the adenine nucleotide translocator. J Biol Chem 1999;274:14429-33.
147. Wallace DC, Murdock DG. Mitochondria and dystonia: the movement disorder connection? Proc Natl Acad Sci USA 1999;96:1817-9.
148. Koehler CM, Leuenberger D, Merchant S, Renold A, Junne T, Schatz G. Human deafness dystonia sydrome is a mitochondrial disease. Proc Natl Acad Sci USA 1999;96:2141-6.
149. Li Y, Huang TT, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genet 1995;11:376-81.
150. Melov S, Coskun P, Patel M, et al. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci USA 1999;96:846-51.
151. Melov S, Schneider JA, Day BJ, et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nature Genet 1998;18:159-63.